Dec 02, 2020
BIVDA Chief Executive Doris-Ann Williams has welcomed the confirmation of the first COVID-19 vaccine to be approved by British regulators. Doris-Ann said; “We are delighted that the MHRA have approved the Pfizer/BioNTech coronavirus vaccine for widespread use, meaning it can start its roll out from next week. On behalf of BIVDA and the in vitro diagnostics sector, I would like to congratulate all those involved in this incredible scientific achievement. An effective v...
Nov 30, 2020
BIVDA Chief Executive Doris-Ann Williams has commented on the launch of the Medicines and Diagnostic Manufacturing Transformation Fund. “We welcome the announcement of the Medicines and Diagnostic Manufacturing Transformation Fund by the Prime Minister today. The lessons the country has learned during this difficult year in pandemic response must not be forgotten, and the innovations should be used to improve our diagnostic testing system for non-COVID illnesses including cancer...
Nov 25, 2020
BIVDA Comments on Spending Review 2020 BIVDA has commented on Chancellor Rishi Sunak’s speech to the House of Commons, where he announced the results of the 2020 Spending Review. Outlining measures designed to help the NHS maintain services as it recovers from the ongoing pandemic, the Chancellor announced £3 billion for recovery projects, including enhanced diagnostic testing, and greater capital spending to help replace outdated diagnostics equipment in hospitals. The NHS budg...
Oct 28, 2020
Please see attached a press release from Paragon Health regarding UK-manufactured PPE supplies.
Oct 16, 2020
BIVDA has commented on the Prime Minister’s statement today declaring that the United Kingdom must prepare for a ‘No Deal’ scenario as talks on an agreement stall. Chief Executive Doris-Ann Williams said; “It is concerning to hear the Prime Minister talking of no deal. The smooth import and export of IVD devices is critical to patient care and any potential impact of delays at our ports and airports would impact the most vulnerable. There is sti...
Oct 05, 2020
BIVDA Comments on Chancellor’s Speech to Conservative Party Conference BIVDA Chief Executive Doris-Ann Williams has commented on Chancellor Rishi Sunak’s speech to the Conservative Party Conference. “While the Chancellor’s speech was light on policy, we recognise that the Government has committed to doing what is necessary to support the economy and health service during what will be a difficult winter. A thriving British IVD industry will be crucial for both tr...
Oct 02, 2020
BIVDA welcomes publication of NHS England diagnostics report. BIVDA has warmly welcomed the publication of ‘Diagnostics: Recovery and Renewal’, a major review of diagnostic services by NHS England. One of the main takeaways from the review is the recommendation for the creation of Community Diagnostic Hubs (CHDs) across the country, away from hospitals, which would act as ‘one stop shops’ so that patients can receive life-saving checks...
Sep 29, 2020
BIVDA Comments on NHS Confederation ‘NHS Reset’ Report The NHS Confederation report focusses on the policy levers needed to put the NHS back onto a secure footing in the months ahead. It aims to: recognise both the sacrifice and achievements of the health and care sector’s response to COVID-19, including the major innovations that have been delivered at pace. rebuild local service provision to meet the physical, mental and social needs of communities affect...
Sep 23, 2020
BIVDA Press Release – For Immediate Release --- BIVDA IVD Market Audit Results Show COVID-19 Impact Report shows substantial impact of COVID-19 pandemic on other diagnostic tests Some diagnostic revenues down by as much as 90% COVID-19 revenues skyrocket The BIVDA Market Audit Report for the first half of 2020 has been published to participants. Twenty seven companies submitted revenue data which has been consolidated into a detailed report on the market size an...